Original
Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease
Jing Qin, Qiongqiong Yang, Xueqing Tang, Wenfang Chen, Zhibin Li, Haiping Mao, Zongpei Jiang, Fengxian Huang and Xueqing Yu
Price
42.00 $
Volume 79 (2013) p. 37 - 44
Abstract
Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease
Jing Qin1,2*, Qiongqiong Yang1,2*, Xueqing Tang1,2, Wenfang Chen3, Zhibin Li4, Haiping Mao1,2, Zongpei Jiang1,2, Fengxian Huang1,2 and Xueqing Yu1,2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 2Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, 3Department of Pathology and 4Epidemiology and Clinical Research Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Both of the authors contributed equally to this work.
Objective: To analyze the clinicopathological features and therapeutic response of nephrotic IgA nephropathy (IgAN) patients with minimal-change disease (MCD). Methods: 62 nephrotic IgAN patients were enrolled between January 2002 and December 2008, and divided into two groups including Group A: patients with MCD-like pathological features, and Group B with non-MCD pathologic pattern. The clinicopathological features, treatments, and responses were then analyzed. Results: 13 (21.0%) patients exhibited MCD-like pathological changes. Patients in Group A presented more prominent proteinuria, hypoalbuminemia but higher hemoglobin and no incidence of renal insufficiency compared to Group B (p < 0.05). 62 patients were treated with corticosteroid, and the complete remission rate in Group A is higher than that in Group B (84.6% vs. 34.7%, p = 0.008), but the relapse rate is much higher in Group A (53.8% vs. 20.4%, p = 0.03). 21 patients were treated combining with immunosuppressant due to unresponsiveness or relapse, which yielded a high re-remission rate in Group A (100%). After follow-up of 53.9 ± 26.9 months, the 5-year renal survival rate is higher in Group A (100%) than that in Group B (84.7%), but no significant difference was observed (p = 0.24). Conclusions: MCD-like pathological changes exist in quite a few nephrotic IgAN patients. These IgAN patients responded well to corticosteroid monotherapy but had a higher rate of relapse. Though manifesting with severe nephrotic symptoms, they tended to have a favorable clinical outcome probably due to the minimal pathological changes. Nevertheless, larger sample size and longer follow-up periods are needed for better understanding of the disease.Correspondence to:
Dr. Xueqing Yu
Department of Nephrology
The First Affiliated Hospital
Sun Yat-sen University
Guangzhou 510080, China
Email: [email protected]
Original
A novel heterozygous deletion-insertion mutation in the desmin gene causes complete atrioventricular block and mild myopathy
Lingling Cao, Daojun Hong, Min Zhu, Xiaobin Li, Hui Wan and Kui Hong
Volume 32 p. 9 - 15
Abstract
Clinical Neuropathology, Vol. 32 – No. 1/2013 (9-15)
A novel heterozygous deletion-insertion mutation in the desmin gene causes complete atrioventricular block and mild myopathy
Lingling Cao1,3*, Daojun Hong2*, Min Zhu2, Xiaobin Li2, Hui Wan2 and Kui Hong1
1Department of Cardiology, The second affiliated hospital of Nanchang University, 2Department of Neurology, The first affiliated hospital of Nanchang University and 3Department of Internal Medicine, The first hospital of Jiujiang City, Jiujiang, Jiangxi Province, China
*The two authors contributed equally to this article.
Defects in the desmin gene have been identified in patients with cardiac and skeletal myopathy characterized by sarcoplasmic accumulation of desmin-positive deposits and electron dense granulofilamentous aggregates. We describe a desminopathy family with unusual clinical features of complete atrioventricular block and mild myopathy. The atrioventricular block can be found in each of the affected members sparing of the detectable cardiac structural abnormalities through echocardiogram. A novel heterozygous deletion-insertion mutation (c.1045-1063 del/G ins), deleting 7 amino acid (Met349-Arg355) and inserting 1 amino acid (Gly349) in a highly conserved alpha-helical 2B domain of desmin, has been identified. The results of this study indicate that atrioventricular conduction block without cardiac structural abnormalities may be an intrinsic feature of disease associated with specific desmin mutation. Furthermore atrioventricular conduction block may be an exclusive clinical manifestation and a major cause of disability and death in some patients with desmiopathy.Correspondence to:
Lingling Cao
Daojun Hong Department of Cardiology
The Second affiliated hospital of Nanchang University
Minde Road 1#, Nanchang, 330006, PR China
Email: [email protected]
Original
Malnutrition-inflammation score predicts long-term mortality in Chinese PD patients
Ting He, Xin An, Hai-Ping Mao, Xin Wei, Jie-Hui Chen, Na Guo, Xiao Yang, Zhi-Bin Li, Xue-Qing Yu and Zhi-Jian Li
Price
42.00 $
Volume 79 (2013) p. 477 - 483
Abstract
Clinical Nephrology, Vol. 79 – No. 6/2013 (477-483)
Malnutrition-inflammation score predicts long-term mortality in Chinese PD patients
Ting He1,2*, Xin An1,2,3*, Hai-Ping Mao1,2, Xin Wei1,2, Jie-Hui Chen1,2, Na Guo1,2, Xiao Yang1,2, Zhi-Bin Li1,2,4, Xue-Qing Yu1,2 and Zhi-Jian Li1,2
1Department of Nephrology, The First Affiliated Hospital, 2Key laboratory of the Ministry of Education, 3Department of Medical Oncology, Cancer Center, and 4Epidemiology and Clinical Research Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*These authors contributed equally to this work.
Background: Malnutrition–Inflammation Score (MIS) has proved to predict the prospective mortality in maintenance hemodialysis (MHD) patients. However, its value of long-term mortality predictability in peritoneal dialysis (PD) patients has not been adequately studied. Methods: A total of 155 chronic stable PD patients from November 2005 to December 2006 were enrolled. At baseline, the MIS, Subjective Global Assessment (SGA), as well as clinical, laboratory, and anthropometric parameters were recorded. All patients were followed until October 2009 to evaluate mortality as a primary outcome. Results: The MIS correlated very well with SGA and other nutrition and inflammation markers. Patients with a higher MIS had a worse survival rate compared to those with lower MIS. After adjusting for potential confounding factors, one unit increase of MIS was associated with a 1.27-fold greater death risk (hazard ratio: 1.27, 95% confidence interval: 1.19 – 1.36; p < 0.001). MIS had a superior mortality predictability compared with SGA. Moreover, univariate and multivariate analyses denoted MIS, age, dialysis vintage, and comorbidities as independent predictors of total mortality. Conclusion: MIS is a promising marker for malnutrition inflammation assessment and an independent predictor of long-term mortality in Chinese PD patients.Correspondence to:
Zhi-Jian Li, MD, PhD
58 Zhongshan 2nd Road
Guangzhou, 510080 China
Email: [email protected]
Original
Tetrandrine induces apoptosis in gallbladder carcinoma in vitro
Ronghua Zhu, Tianyu Liu, Zhujun Tan, Xiangsong Wu, Maolan Li, Lin Jiang, Runfa Bao, Yijun Shu, Aiguo Lu, and Yingbin Liu
Price
42.00 $
Volume 52 p. 900 - 905
Abstract
International Journal of Clinical Pharmacology and Therapeutics, Vol. 52 – No. 10/2014 (900-905)
Tetrandrine induces apoptosis in gallbladder carcinoma in vitro
Ronghua Zhu1*, Tianyu Liu2*, Zhujun Tan2, Xiangsong Wu2, Maolan Li2, Lin Jiang2, Runfa Bao2, Yijun Shu2, Aiguo Lu1, and Yingbin Liu2
1Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, and 2Department of General Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Objective: The aims of this study were to observe the apoptosis effects of tetrandrine on human gallbladder carcinoma cell line (SGC-996), and to explore its related mechanism. Methods: First, the anti-proliferative activities of tetrandrine on SGC-996 cells were determined by using the MTT assays. Then, cell cycle changes were detected by flow cytometry analysis. The apoptosis of cells was detected by the annexin V/propidium iodide double-staining assay. Detection of mitochondrial membrane potential was used to validate the ability of tetrandrine on inducing apoptosis. Finally, the expressions of the apoptosis-related proteins (caspase-3, PARP, Bcl-2, and Bax) were analyzed by western blot. Statistical analyses were performed using the Student’s t-test for comparison of the results obtained from cells with or without treatment of tetrandrine. Results: The MTT assay revealed a significant inhibition of cell proliferation in a dose- and time-dependent manner. Cells treated with tetrandrine were arrested at the S phase, according to the flow cytometric analysis. Tetrandrine produced a dose-dependent increase in the apoptotic cell population compared with control cells. Tetrandrine can also affect mitochondrial function by changing the mitochondrial membrane potential. Furthermore, western blot assay demonstrated that the tetrandrine induced apoptosis in SGC-996 cells by regulating the ratio of Bcl-2/Bax and activating the expression of cleaved caspase-3. Conclusions: The results indicate that tetrandrine may be a potential agent for the treatment of gallbladder carcinoma.
*These authors contributed equally to this work.Correspondence to:
Dr. Ying-bin Liu
Department of General Surgery, Xinhua Hospital
Shanghai Jiaotong University School of Medicine
No. 1665 Kongjiang Road, Shanghai 200092, China
Email: [email protected]
Original
Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria
Zhen Ai, Ricong Xu, Wenting Liu, Qian Zhou, Bin Li, Fengxian Huang, Xueqing Yu, and Qiongqiong Yang
Price
42.00 $
Volume 86 (2016) p. 35 - 41
Abstract
Clinical Nephrology, Vol. 86 – No. 1/2016 (35-42)
Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria
Zhen Ai1#2, Ricong Xu1#2, Wenting Liu1#2, Qian Zhou3, Bin Li3, Fengxian Huang1#2, Xueqing Yu1#2, and Qiongqiong Yang1#2
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 2Key Laboratory of Nephrology, Ministry of Health and Guangdong Province, and 3Epidemiology Research Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Aims: To investigate the clinicopathologic features of IgA nephropathy (IgAN) patients with different levels of proteinuria and its clinical significance. Methods: This was a single-center retrospective cohort study. Patients with biopsy-proven primary IgAN were enrolled from January 2006 to December 2011 in The First Affiliated Hospital of Sun Yat-sen University, divided into six groups based on proteinuria at biopsy (≤ 0.30 g/d, 0.31 – 0.50 g/d, 0.51 – 1.00 g/d, 1.01 – 2.00 g/d, 2.01 – 3.00 g/d, and > 3.00 g/d). Demographic and clinicopathologic data were collected and analyzed. Results: 1,413 patients were enrolled in this study, with the median proteinuria being 0.61 g/d (interquartile range 0.30 – 1.29). Patients with proteinuria > 0.50 g/d showed significant differences in their clinicopathologic characteristics with higher prevalence of hypertension, hypoalbuminemia, hyperuricemia, hypercholesterolemia and hypertriglyceridemia, worse renal function, higher proportions of segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, and interstitial inflammation. Even the patients with proteinuria 0.31 – 0.50 g/d exhibited higher uric acid, lower total serum protein and albumin, higher proportions of crescents, and global glomerulosclerosis. Furthermore, multiple risk factors linear regression analysis has shown that there were significant associations between proteinuria and serum albumin, uric acid, total cholesterol, triglyceride, systolic blood pressure, degrees of segmental glomerulosclerosis, proportions of crescents, and global glomerulosclerosis. Conclusion: Clinicopathologic features were significantly worse in IgAN patients with increasing of proteinuria.Correspondence to:
Qiongqiong Yang MD, PhD, Professor of Medicine
Department of Nephrology, The First Affiliated Hospital
Sun Yat-sen University
58th Zhongshan Road II, Guangzhou 510080, China
Email: [email protected]
Original
The spectrum of biopsy-proven secondary glomerular diseases: A cross-sectional study in China
Ping Wang, Lijun Tang, Jing Yao, Hong Su, Yipeng Liu, Xianglei Kong, Wenbin Li, Meiyu Cui, Qing Sun, Junhui Zhen, and Dongmei Xu
Price
42.00 $
Volume 88 (2017) p. 270 - 276
Abstract
Clinical Nephrology, Vol. 88 – No. 5/2017 (270-276)
The spectrum of biopsy-proven secondary glomerular diseases: A cross-sectional study in China
Ping Wang1*, Lijun Tang1*, Jing Yao2, Hong Su1, Yipeng Liu1, Xianglei Kong1, Wenbin Li1, Meiyu Cui1, Qing Sun3, Junhui Zhen4, and Dongmei Xu1
1Department of Nephrology, Qianfoshan Hospital, Shandong University,
2The Blood Purification Center, Shandong Veterans General Hospital,
3Department of Pathology, Qianfoshan Hospital, Shandong University, and 4Department of Pathology, School of Medicine, Shandong University, Jinan, China
Aims: The distribution of the spectrum of chronic kidney disease (CKD) has been found to vary with time. Limited information is available regarding the changing spectrum of secondary glomerular diseases (SGDs). To further investigate changes in the spectrum of SGDs, we performed a cross-sectional study. Methods: From June 2010 to May 2015, 5,935 patients from 37 hospitals in Shandong Province were involved in this study. The study was divided into five periods according to 1-year intervals. The patients were divided into four age groups. Results: Of the 5,935 patients with qualified specimens, 1,038 (17.5%) were diagnosed with a SGD. Lupus nephritis (LN) (27.6%) was the most frequently identified SGD, followed by Henoch-Schönlein purpura glomerulonephritis (HSPN) (21.7%) and diabetic nephropathy (DN) (21.6%). The prevalence rate of DN demonstrated an increasing trend, and this condition became the leading cause of renal biopsy in period 3 (29.3%). The proportion of patients with hepatitis B virus-associated nephritis (HBVAN) decreased from 14.7% in period 2 to 5.1% in period 5 (p < 0.001). The proportion of patients with amyloidosis nephropathy (AN) increased from 2.2% in period 1 to 7.0% in period 5 (p = 0.088). The prevalence rate of DN was 0.6% in pediatric patients and 40.7% in elderly patients (p < 0.001). Conclusions: In our study, SGD was the second leading cause of renal biopsy. The distribution of the spectrum of SGD varied with time and age. Given the possibility of a detection bias, larger prospective cohort studies are needed in the future.
*These authors contributed equally to this work.Correspondence to:
Dongmei Xu, PhD
Department of Nephrology, Qianfoshan Hospital
Shandong University
No.16766, Jingshi Road, Jinan 250014, People’s Republic of China
Email: qianyixdmgmail@
163.com
Original
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions
Xiaojiao Li, Hong Zhang, Xiaoxue Zhu, Cuiyun Li, Hong Chen, Jingrui Liu, Guiling Chen, Min Wu, Chengjiao Liu, Zhenwei Shen, Junqi Niu, Bin Liu, and Yanhua Ding
Price
42.00 $
Volume 56 (2018) p. 434 - 442
Abstract
International Journal of Clinical Pharmacology and Therapeutics, Vol. 56 – No. 9/2018 (434-442)
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions
Xiaojiao Li1, Hong Zhang1, Xiaoxue Zhu1, Cuiyun Li1, Hong Chen1, Jingrui Liu1, Guiling Chen1, Min Wu1, Chengjiao Liu1, Zhenwei Shen1, Junqi Niu2, Bin Liu3, and Yanhua Ding1
1Phase I Clinical Trial Unit, 2Department of Hepatology, and
3Hand Surgery Department, First Hospital, Jilin University, Jilin, China
Objective: Desmopressin acetate (DDAVP®) is a synthetic analogue of the pituitary hormone vasopressin. Until now, few studies of desmopressin have focused on the pharmacokinetics (PK) or food effects in Asian populations. This study aimed to assess the effect of food intake on the PK of desmopressin and bioequivalence of two tablet formulations in Chinese subjects. Materials and methods: A single-center, single-dose, randomized, open-label, two-period crossover study was conducted in 104 healthy Chinese volunteers under fasted or fed conditions (52 volunteers for each condition). Blood samples were collected up to 14 hours after administration of oral desmopressin tablets (0.6 mg; 0.2 mg × 3) in each period. Plasma desmopressin concentrations were analyzed by validated liquid chromatography-tandem mass spectrometry (LC-MS/MS). PK and bioavailability parameters were calculated. Adverse events (AEs) were also recorded. Results: No significant differences in mean (standard deviation, SD) PK parameters were observed between formulation 1 (F1) and formulation 2 (DDAVP®; F2) under both fasted and fed conditions. All AEs observed were mild and resolved quickly without treatment. The maximum concentration (C<sub>max</sub>) and area under the curve (AUC) were significantly decreased (p < 0.01) when the drug was taken with food, compared with fasted subjects. Conclusion: These findings suggest that both tablet formulations were well tolerated. Food can significantly decrease the exposure of desmopressin.
Correspondence to:
Bin Liu
Hand Surgery Department, First Hospital,
Jilin University
No. 71 Xinmin Street,
Changchun 130021, China
Email: [email protected]
Bioavailability Section
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
Cuiyun Li, Yanhua Ding, Deming Yang, Meng Wang, Yue Hu, Hong Zhang, Xiaoxue Zhu, Guiling Chen, Xiaojiiao Li, Min Wu, Jingrui Liu, Hong Chen, Chengjiao Liu, Zhenwei Shen, and Bin Liu
Price
42.00 $
Volume 56 (2018) p. 562 - 570
Abstract
International Journal of Clinical Pharmacology and Therapeutics, Vol. 56 – No. 11/2018 (562-570)
Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
Cuiyun Li1, Yanhua Ding1, Deming Yang1, Meng Wang1, Yue Hu1, Hong Zhang1, Xiaoxue Zhu1, Guiling Chen1, Xiaojiiao Li1, Min Wu1, Jingrui Liu1, Hong Chen1, Chengjiao Liu1, Zhenwei Shen2, and Bin Liu3
1Phase I Clinical Unit, China-Frontage USA, First Hospital, 2First Hospital and Institute of Immunology, and 3Department of Hand Surgery, First Hospital, Jilin University, Changchun, Jilin, China
Objective: This study was designed to evaluate the pharmacokinetic (PK) properties and bioequivalence (BE) of two 250-mg tablet formulations of abiraterone acetate: a newly developed generic formulation (test) and a branded formulation (reference) in healthy adult Chinese subjects under fasted (n = 40) and fed (n = 40) conditions. Materials and methods: The comparison was performed using a single-dose, open, randomized, and four-way replicate study. The concentration of abiraterone in blood samples taken over 48 hours was determined by liquid chromatography tandem mass spectrometry (LC-MS/MS). To assess the BE of the test and reference formulations, confidence intervals (CI, 90%) for the peak plasma concentration (C<sub>max</sub>) and area under the concentration-time curves (AUC<sub>0–t</sub> and AUC<sub>0–∞</sub>) were calculated using the reference-scaled average bioequivalence (RSABE) method. Results: The results showed that the 90% CIs for the ratios of C<sub>max</sub>, AUC<sub>0–t</sub>, and AUC<sub>0–∞</sub> in the fasted study were 90.14 – 114.11, 93.96 – 115.07, and 93.72 – 113.331, respectively. For the fed study, the 90% CIs were 81.83 – 102.51, 91.51 – 104.89, and 91.46 – 104.58, respectively. Conclusion: In conclusion, the tested 250-mg abiraterone tablets were bioequivalent to 250-mg Zytiga tablets (reference) under both fasted and fed conditions. In addition, food intake increased the systemic exposure and C<sub>max</sub> of abiraterone by 3-fold and 7-fold, respectively.
Correspondence to:
Prof. Bin Liu, MD
Department of Hand Surgery
First Hospital, Jilin University, Changchun, Jilin, 130021, China
Email: [email protected]